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MOTS-c, a mitochondrially encoded open reading frame-derived peptide recently discovered by Lee et al.
2015 (this issue ofCell Metabolism) promotes biosynthesis of an endogenous AMP analog, AICAR. As AICAR
activates AMPK, the discovery of MOTS-c offers an unexpected therapeutic option to be exploited toward
the prevention of type 2 diabetes and delaying of the aging processes.Mitochondria serve as the powerhouses
of the cell by converting nutritional
substrates into readily available energy
sources including adenosine tri-phos-
phate (ATP). These organelles have
evolved from bacterial endosymbionts
that became integrated into eukaryotic
cells, and which carry their own genome
encoding for a limited number of well-
characterized proteins. Mitochondria
have previously been shown to generate
a number of messaging molecules that
are capable of inducing programmed
cell death or initiating transcriptional
responses within the nucleus (Yun and
Finkel, 2014). The latter, also known as
retrograde response, is mediated by
reactive oxygen species (ROS) and has
been linked to amelioration of metabolic
disorders (Ristow et al., 2009) and exten-
sion of lifespan (Schulz et al., 2007). Like-
wise, an undisclosed peptidic mitokine
was proposed to regulate organismal
aging in a cell non-autonomous manner
(Durieux et al., 2011).
Recently, Pinchas Cohen and col-
leagues have performed in silico analyses
for potential mitochondrial open reading
frames (mtORFs), and have identified
a mitochondria-derived peptide (MDP)
named humanin that protects neuronal
and vascular systems from disease pro-
cesses and toxic insults (Lee et al.,
2013). The same group has identified
and characterized a second mtORF-en-
coded peptide named MOTS-c that is
located within the sequence coding for
mitochondrial 12S rRNA, and which
ultimately promotes activation of AMP-
activated protein kinase (AMPK), a
well-characterized regulator of energy
metabolism capable of ameliorating type
2 diabetes and related disorders likeobesity (Lee et al., 2015 [this issue of
Cell Metabolism]).
By applying a combination of experi-
mental approaches the authors demon-
strate that MOTS-c is acting in a systemic
manner, and hence qualifies as a hor-
mone. While its expression is found to
be decreased in states of caloric restric-
tion (CR) in both plasma aswell as skeletal
muscle, MOTS-c appears to increase
methionine turnover, and consistently
block the de novo biosynthesis of purine
nucleotides. The latter causes accumu-
lation of AICAR, a well-defined AMPK
activator (Hardie, 2014). Notably, a long-
standing antidiabetic drug, metformin,
has also been shown to act through
activation of AMPK (Hardie, 2014), and
additionally to extend organismal health-
span by affecting methionine metabolism
(Cabreiro et al., 2013).
In a similar, however not fully identical
manner, MOTS-c induces cellular and
systemic glucose uptake, and hence
improves insulin sensitivity in mice. This
is of particular interest, since endogenous
MOTS-c levels decrease with age, and so
does insulin sensitivity. Moreover, admin-
istering MOTS-c to mice by injection
prevents diet-induced obesity (DIO) to a
significant extent, and resistance to DIO
appears to be related to increased body
temperature, while the respiratory quo-
tient is shifted toward carbohydrate
metabolism, and MOTS-c decreases
both OXPHOS as well as respiration.
These latter observations, however, are
in conflict with the fact that metabolite
profiles of MOTS-c-treated specimen
indicate an increase in fatty acid oxida-
tion—which should decrease the respira-
tory quotient in rodents. Likewise, the
increase in body temperature pointsCell Metabolismtoward increased uncoupling by inducing
uncoupling proteins (UCPs). This would
explain the protection from weight gain;
however, it requires increased proton
leak typically reflected by an increase
(rather than a decrease, as observed
with MOTS-c) in oxygen consumption.
Moreover, the fact that MOTS-c strongly
reduces respiration while increasing
anaerobic glycolysis in cultured cells
raises concern regarding the potential
promotion of malignant growth of pre-
existing cancers in vivo, as shown multi-
ple times for this type of metabolic switch
since its initial observation (Warburg et al.,
1924). In addition, the authors observe an
accumulation of homocysteine following
MOTS-c application, the former being a
well-established risk factor of cardiovas-
cular disease and particularly atheroscle-
rosis (Boushey et al., 1995).
At the current state, the MDP MOTS-c
may be considered an exciting peptidic
hormone by which mitochondria gene-
rate a signal that acts in a systemic
manner to shift energy demands and
expenditure. Also due to its partly NAD+/
sirtuin 1-dependent action, MOTS-c
could translate into a valuable therapeutic
approach not only for the treatment of
obesity and type 2 diabetes, but also,
and like other mitochondrial signals
(Durieux et al., 2011; Ristow et al., 2009;
Schulz et al., 2007; Yun and Finkel,
2014), to prevent aging and to extend
healthspan.REFERENCES
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